JOHN KELLY: Open Payments
NPI 1265540686 · BLOOMFIELD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$877 in 53 payments from 16 companies in 2025. Trend: 2023 $989 · 2024 $994 · 2025 $877
Food & beverage: $877
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $253 |
| PFIZER INC. | 6 | $98 |
| Novo Nordisk Inc | 6 | $96 |
| Exact Sciences Corporation | 3 | $80 |
| Lilly USA, LLC | 3 | $53 |
| Stryker Corporation | 1 | $52 |
| Kowa Pharmaceuticals America, Inc. | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 3 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
Products named: UBRELVY, Cologuard Collection Kit, QULIPTA, NURTEC ODT, Wegovy, PANGEA, ZORYVE, VRAYLAR.
Industry payments across NJ — which companies pay providers there.
